Choline kinase alpha in cancer prognosis and treatment
- 1 October 2007
- journal article
- other
- Published by Elsevier in The Lancet Oncology
- Vol. 8 (10) , 855-857
- https://doi.org/10.1016/s1470-2045(07)70289-9
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective studyThe Lancet Oncology, 2007
- Lactate, choline, and creatine levels measured by vitro 1H‐MRS as prognostic parameters in patients with non‐small‐cell lung cancerJournal of Magnetic Resonance Imaging, 2007
- Phosphocholine as a biomarker of breast cancer: Molecular and biochemical studiesInternational Journal of Cancer, 2007
- Choline metabolism in cancer: implications for diagnosis and therapyExpert Review of Molecular Diagnostics, 2006
- RNA Interference–Mediated Choline Kinase Suppression in Breast Cancer Cells Induces Differentiation and Reduces ProliferationCancer Research, 2005
- Alterations of Choline Phospholipid Metabolism in Ovarian Tumor ProgressionCancer Research, 2005
- Structure and function of choline kinase isoforms in mammalian cellsProgress in Lipid Research, 2004
- Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancersBiochemical and Biophysical Research Communications, 2002